086450.KQ KOE
DongKook Pharmaceutical Co., Ltd.
1W: +6.6%
1M: +3.9%
3M: +12.9%
YTD: +23.0%
1Y: +22.5%
3Y: +70.2%
5Y: -15.9%
₩22,750.00 ($16.95)
+600.00 (+2.71%)
Weekly Expected Move ±5.4%
₩20300
₩21525
₩22750
₩23975
₩25200
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$72.0B
-5.4% ▼
5Y CAGR: +4.0%
Capital Expenditures
$42.5B
-37.8% ▼
5Y CAGR: +0.5%
Free Cash Flow
$29.5B
-34.8% ▼
5Y CAGR: +10.1%
Dividends Paid
$9.2B
-11.2% ▼
Buybacks
$0
+0.0% ▲
Net Change in Cash
$5.9B
+157.5% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $50.3B | $52.9B | $48.9B | $62.3B | $66.0B |
| Depreciation & Amort. | $17.3B | $19.2B | $21.1B | $28.5B | $0 |
| Stock-Based Comp. | -$24M | -$297M | -$162M | -$39M | $0 |
| Change in Working Capital | -$22.3B | -$39.0B | -$35.2B | -$24.6B | -$44.4B |
| Other Non-Cash Items | -$738M | $8.2B | $7.1B | $9.9B | $50.4B |
| Operating Cash Flow | $44.7B | $40.9B | $41.8B | $76.1B | $72.0B |
| — Investing Activities — | |||||
| Capital Expenditures | -$51.4B | -$51.2B | -$34.2B | -$26.6B | -$45.7B |
| Acquisitions (Net) | -$13.0B | $25M | $3.6B | -$27.3B | $13.4B |
| Investment Purchases | -$216.2B | -$261.7B | -$155.4B | -$60.3B | -$134.0B |
| Investment Sales | $232.9B | $292.8B | $134.2B | $52.1B | $99.8B |
| Other Investing | $1.9B | $7.7B | -$663M | -$2.8B | -$467M |
| Investing Cash Flow | -$45.8B | -$12.4B | -$52.4B | -$64.9B | -$67.0B |
| — Financing Activities — | |||||
| Net Debt Issuance | $42.3B | -$30.2B | $10.8B | -$8.1B | -$4.1B |
| Stock Repurchased | $0 | $0 | -$2.5B | $0 | $0 |
| Dividends Paid | -$8.0B | -$8.0B | -$8.1B | -$8.3B | -$9.2B |
| Other Financing | -$4.6B | -$1.6B | -$5.0B | -$5.9B | -$3.3B |
| Financing Cash Flow | $29.7B | -$39.8B | -$2.3B | -$22.3B | $1.2B |
| Net Change in Cash | $30.9B | -$11.8B | -$13.1B | -$10.3B | $5.9B |
| Cash End of Period | $85.4B | $73.7B | $60.6B | $50.3B | $56.2B |
| Free Cash Flow | -$7.2B | -$2.1B | $2.4B | $45.3B | $29.5B |